Dexmethylphenidate Hydrochloride Tablet
Product Images NDC 10702-108

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dexmethylphenidate Hydrochloride (NDC 10702-108). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kvk-tech, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

6f4edd9f Figure 05

6f4edd9f Figure 05
FDA Label Image

6f4edd9f Figure 06

6f4edd9f Figure 06
FDA Label Image

6f4edd9f Figure 07

6f4edd9f Figure 07
FDA Label Image

Chemical Formula Figure 01

Chemical Formula Figure 01
FDA Label Image

Company Logo Figure 04

Company Logo Figure 04
FDA Label Image

Table 3 Figure 02

Table 3 Figure 02
This table presents efficacy results from a study on the treatment of ADHD in pediatric patients aged 6-17 years. The primary efficacy measure was the Teacher SNAP-ADHD Total Score, and the table summarizes the Mean Baseline Score, Mean change from baseline to week 4, and Week 4 Score for the Treatment Group (n=42) and Placebo Group (n=41). The results show a statistically significant difference between the two groups, with the Treatment Group demonstrating greater improvement in symptoms.*
FDA Label Image

Table 4 Figure 03

Table 4 Figure 03
This is a summary of the efficacy results from a randomized withdrawal study focusing on attention deficit hyperactivity disorder (ADHD) treatment in pediatric patients aged 6 to 17. The study (Study 2) compares the proportion of treatment failures between the Focalin 5-20mg/day treatment group and placebo. Out of the 35 randomized patients, 6 (17.1%) failed in the Focalin group while 25/40 (62.5%) failed in the placebo group. The Focalin treatment was statistically significantly better than the placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.